Dermatology Devices Market worth $17.73 billion by 2031
The report "Dermatology Devices Market by Type (Diagnostic (Dermatoscopes, Microscopes), Treatment (Laser, Cryotherapy), Application (Diagnostic, Medical Therapeutic, Aesthetic Therapeutic), Technology (Light), End User (Hospitals), Region - Global Forecast to 2031", is projected to grow from USD 9.32 billion in 2026 and to reach USD 17.73 billion by 2031, at a Compound Annual Growth Rate (CAGR) of 13.7% during the forecast period.
Browse 444 market data Tables and 43 Figures spread through 340 Pages and in-depth TOC on "Dermatology Devices Market by Type (Diagnostic (Dermatoscopes, Microscopes), Treatment (Laser, Cryotherapy), Application (Diagnostic, Medical Therapeutic, Aesthetic Therapeutic), Technology (Light), End User (Hospitals), Region - Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/dermatology-market-154.html
The dermatology devices market is growing steadily, driven by rising prevalence of skin disorders and skin cancer, as well as increasing demand for minimally invasive and noninvasive aesthetic procedures worldwide. Growing beauty consciousness, social media influence, and an aging population seeking anti-aging and skin rejuvenation treatments are further boosting adoption of advanced dermatology devices. Ongoing advances in laser, radiofrequency, HIFU, light-based, and imaging technologies are improving treatment precision, safety, and clinical outcomes, supporting broader adoption across healthcare and aesthetic settings. Expansion of dermatology clinics and aesthetic centers, rising disposable incomes, and greater access to dermatology services in emerging markets are also contributing to market growth. However, high costs of advanced dermatology devices, limited reimbursement for aesthetic procedures, stringent regulatory requirements, and the risk of procedure-related adverse events may, to some extent, restrain market growth.
By technology, the laser-based segment accounted for the largest share of the dermatology devices market in 2025.
The dermatology devices market is segmented into laser-based, ultrasound-based, light-based, cryotherapy-based, radiofrequency (RF)-based, and other technologies. In 2025, the laser-based segment accounted for the largest share of the dermatology devices market. This dominance is primarily driven by the widespread adoption of laser-based devices across medical and aesthetic dermatology applications. These devices are widely used for hair removal, skin rejuvenation, scar revision, tattoo removal, treatment of vascular and pigmented lesions, and selected skin cancer therapies. In addition, continuous technological advancements in laser platforms, increasing preference for minimally invasive procedures, high treatment precision and clinical efficacy, and shorter patient recovery times have strengthened the adoption of laser-based technologies. Furthermore, growing demand for cosmetic dermatology procedures, rising patient awareness, and the rapid expansion of dermatology clinics and aesthetic centers worldwide are further contributing to the growth of this segment.
By end user, the hospitals, dermatology clinics, and medical facilities segment accounted for the largest share of the dermatology devices market in 2025.
The dermatology devices market is segmented into hospitals, dermatology clinics, and medical facilities, beauty centers, and home care settings. In 2025, the hospitals, dermatology clinics, and medical facilities segment accounted for the largest share of the dermatology devices market. This dominance is primarily attributed to the availability of advanced diagnostic and therapeutic dermatology equipment, the presence of skilled dermatologists and multidisciplinary specialists, and the high volume of both medical and aesthetic procedures performed in these facilities. These healthcare settings also manage complex skin disorders, skin cancer diagnosis and treatment, and procedures requiring advanced technologies such as lasers, radiofrequency, HIFU, and other energy-based devices that are typically unavailable in beauty centers or home care settings. Furthermore, increasing patient preference for specialized dermatology care, growing investments in healthcare infrastructure, and an expanding network of dermatology clinics are contributing to the growth of this segment.
North America is the largest regional market for dermatology devices.
The dermatology devices market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2025, North America accounted for the largest share of the dermatology devices market. This dominance is driven by a high volume of medical and aesthetic dermatology procedures, a well-established healthcare infrastructure, and the widespread adoption of advanced dermatology technologies. The region also benefits from a growing aging population, rising prevalence of skin disorders and skin cancer, high disposable incomes, and strong patient awareness of aesthetic treatments. In addition, favorable reimbursement for selected medical dermatology procedures, continuous technological advancements, frequent product launches and regulatory approvals, and the increasing adoption of minimally invasive procedures have strengthened market growth. Furthermore, the strong presence of leading dermatology device manufacturers and specialized dermatology clinics continues to support North America's leadership in the global market.
The major players operating in this market are Sisram Medical Ltd (Israel), Bausch Health Companies Inc. (Canada), Lumenis Be Ltd. (Israel), El.En. S.p.A. (Italy), InMode Ltd. (Israel), AbbVie Inc. (US), Cutera, Inc. (US), Cynosure Lutronic (US), Candela Corporation (US), and BTL Group of Companies (Czech Republic), among others.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Dermatology Devices Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
